The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Eli Lilly and Co

NYSE: LLY
Last

(U.S.) $85.09

Today's change-0.59 -0.69%
Updated July 29 4:04 PM EDT. Delayed by at least 15 minutes.
 

Eli Lilly and Co

NYSE: LLY
Last

(U.S.) $85.09

Today's change-0.59 -0.69%
Updated July 29 4:04 PM EDT. Delayed by at least 15 minutes.

Eli Lilly and Co down (U.S.)$0.59

Eli Lilly and Co closed lower Wednesday, dropping (U.S.)$0.59 or 0.69% to (U.S.)$85.09. Shares have lost 1.49% over the last five days, but have gained 23.34% over the last year to date. This security has outperformed the S&P 500 by 28.52% during the last year.

Key company metrics

  • Open(U.S.) $85.91
  • Previous close(U.S.) $85.68
  • High(U.S.) $85.99
  • Low(U.S.) $84.71
  • Bid / Ask(U.S.) $83.05 / (U.S.) $85.19
  • YTD % change+23.34%
  • Volume2,709,839
  • Average volume (10-day)5,804,324
  • Average volume (1-month)5,468,011
  • Average volume (3-month)5,541,286
  • 52-week range(U.S.) $60.14 to (U.S.) $90.18
  • Beta0.31
  • Trailing P/E44.08×
  • P/E 1 year forward26.32×
  • Forward PEG2.57×
  • Indicated annual dividend(U.S.) $2.00
  • Dividend yield2.35%
  • Trailing EPS(U.S.) $1.93
Updated July 29 4:04 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+10.50%

Based on its net profit margin of 10.50%, Eli Lilly and Co is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX1.59%Sector:HealthcareIndustry:Pharmaceuticals - Diversified
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2015Q1/2015Q4/2014Q3/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014Sep 30, 201409/30/2014
Revenue4,9794,6455,1214,876
Total other revenue--------
Total revenue4,9794,6455,1214,876
Gross profit3,7603,4523,8683,609
Total cost of revenue1,2181,1931,2531,267
Total operating expense4,1764,1204,7454,314
Selling / general / administrative1,6351,5241,8001,672
Research & development1,1701,0391,1861,243
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)152364506131
Other operating expenses, total--------
Operating income803525376562
Interest income (expense), net non-operating---54-49-48
Gain (loss) on sale of assets--------
Other--------
Income before tax680618514656
Income after tax601530429501
Income tax, total798885155
Net income601530429501
Total adjustments to net income--------
Net income before extra. items601530429501
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items601530429501
Inc. avail. to common incl. extra. items601530429501
Diluted net income601534429501
Dilution adjustment--4----
Diluted weighted average shares1,0661,0671,0701,074
Diluted EPS excluding extraordinary itemsvalue per share0.560.500.400.47
Dividends per sharevalue per share0.500.500.500.49
Diluted normalized EPSvalue per share0.700.830.810.58